Cenicriviroc
Cenicriviroc (TAK-652) is an orally bioavailable dual CCR2 and CCR5 antagonist. It exhibits anti-HIV-1/2 activity and has been investigated in research for its anti-inflammatory effects in models of liver and kidney fibrosis, both in vitro and in vivo.
Product Specifications
CAS Number
497223-25-3
Product Name Alternative
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
97.87% (May vary between batches)
Solubility
DMSO:120 mg/mL (172.18 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (5.74 mM)
Smiles
CC (C) CN1CCC/C (C (NC2=CC=C ([S@] (CC3=CN=CN3CCC) =O) C=C2) =O) =C\C4=CC (C5=CC=C (OCCOCCCC) C=C5) =CC=C41
Molecular Formula
C41H52N4O4S
Molecular Weight
696.94
Storage Conditions
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Equine herpesvirus 1 Virion host shutoff protein (19)
Recombinant Equine herpesvirus 1 Virion host shutoff protein (19)
Recombinant Equine herpesvirus 1 Virion host shutoff protein (19)
Recombinant Equine herpesvirus 1 Virion host shutoff protein (19)